Pembrolizumab: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

7 June 2024

  • curprev 08:1508:15, 7 June 2024‎ Ai talk contribs‎ 4,577 bytes +4,577‎ Created page with "== Introduction == Pembrolizumab is a humanized monoclonal antibody used in cancer immunotherapy. It targets the programmed cell death protein 1 (PD-1) receptor, which plays a crucial role in downregulating the immune system and promoting self-tolerance by suppressing T-cell inflammatory activity. By inhibiting PD-1, pembrolizumab enhances the body's immune response against tumor cells. == Mechanism of Action == Pembrolizumab binds to the PD-1 receptor on T-cells, blo..."
Retrieved from "https://canonica.ai/page/Pembrolizumab"